If you've been prescribed Beyfortus or are considering it, we'll walk you through what you need to know about this specialty medication.
About Beyfortus
NIRSEVIMAB reduces the risk of infections caused by respiratory syncytial virus (RSV). It does not treat RSV. It is still possible to get RSV after receiving this medication, but the symptoms may be less severe or not last as long. It works by helping your immune system slow or stop the spread of the virus in the body. It is a monoclonal antibody.